Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 12:21 PM ET

Date/Time Source News Release
05/12/2025 07:30 AM EDT GlobeNewswire ProMIS Neurosciences Announces First Quarter 2025 Financial Results
03/31/2025 07:00 AM EDT GlobeNewswire ProMIS Neurosciences Announces Full Year 2024 Financial Results and Recent Highlights
03/24/2025 07:00 AM EDT GlobeNewswire ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer's Disease/Parkinson's Disease 2025 International Conference
03/13/2025 07:00 AM EDT GlobeNewswire ProMIS Neurosciences Showcases Preclinical Data on Platform Derived Vaccines for Neurodegenerative Diseases at the American Academy of Neurology 2025 Annual Meeting
03/11/2025 07:30 AM EDT GlobeNewswire ProMIS Neurosciences to Participate in the 37th Annual Roth Conference
02/25/2025 07:00 AM EST GlobeNewswire ProMIS Neurosciences Doses First Patients in Phase 1b PRECISE-AD Trial of PMN310 for Alzheimer's Disease
01/29/2025 07:30 AM EST GlobeNewswire ProMIS Neurosciences to Participate in Guggenheim Securities SMID Cap Biotech Conference
01/13/2025 10:30 AM EST GlobeNewswire ProMIS Neurosciences Issues Letter to Shareholders
01/10/2025 07:00 AM EST GlobeNewswire ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer's Disease
11/26/2024 07:00 AM EST GlobeNewswire ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference
Page

Additional News

As of June 3, 2025 • 12:21 PM ET

Date/Time Source News Release
07/11/2022 10:42 AM EDT Baystreet ProMIS, Recharge, Atlas at 52-Week Highs on News
11/15/2021 02:30 PM EST InvestorBrandNetwork Q4 Investor Summit Small Cap & Micro Cap Conference To Offer Opportunity to Meet with C-level Management of 90+ Companies
09/25/2020 07:00 AM EDT Stockhouse The Big Movers in Healthcare this Week
06/17/2020 01:08 PM EDT Baystreet ProMIS Neurosciences, Inc.
06/17/2020 11:30 AM EDT Baystreet American Lithium, Quarterhill at 52-Week Highs on News
03/25/2020 10:30 AM EDT InvestorBrandNetwork NetworkNewsBreaks - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF) Announces Annual Results for Fiscal Year 2019, Approval for Warrant Repricing
04/09/2019 06:30 PM EDT Investing News Network 5 Top Biotech Stocks on the TSX Year-to-Date
01/28/2019 07:45 AM EST ACCESSWIRE IA Today's Research Reports on Oncolytics Biotech, Delivra, Aptose Biosciences and ProMIS Neurosciences
01/23/2019 10:26 AM EST Stockhouse ProMis Completes $2.2 Million Private Placement
01/17/2019 09:58 AM EST Stockhouse ProMIS Neurosciences Heading to NobleCon15 & CanTech
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.